Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.510
+0.170 (7.26%)
At close: Apr 28, 2026, 4:00 PM EDT
2.496
-0.014 (-0.57%)
After-hours: Apr 28, 2026, 7:19 PM EDT
Context Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 7.85 | 7.22 | 7.29 | 7.79 | 3.63 | |
| Research & Development | 31.86 | 22.7 | 17.78 | 7.09 | 3.81 | |
| Operating Expenses | 39.7 | 29.92 | 25.07 | 14.88 | 7.44 | |
| Operating Income | -39.7 | -29.92 | -25.07 | -14.88 | -7.44 | |
| Interest Expense | - | - | - | - | -0.06 | |
| Interest & Investment Income | 3.38 | 3.2 | 1.16 | 0.55 | - | |
| Other Non Operating Income (Expenses) | 0.2 | -0 | -0.06 | -0 | 0.01 | |
| EBT Excluding Unusual Items | -36.12 | -26.73 | -23.96 | -14.34 | -7.49 | |
| Other Unusual Items | - | - | - | - | 0.13 | |
| Pretax Income | -36.12 | -26.73 | -23.96 | -14.84 | -10.46 | |
| Net Income | -36.12 | -26.73 | -23.96 | -14.84 | -10.46 | |
| Net Income to Common | -36.12 | -26.73 | -23.96 | -14.84 | -10.46 | |
| Shares Outstanding (Basic) | 95 | 58 | 16 | 16 | 3 | |
| Shares Outstanding (Diluted) | 95 | 58 | 16 | 16 | 3 | |
| Shares Change (YoY) | 62.94% | 265.88% | - | 463.44% | 37.90% | |
| EPS (Basic) | -0.38 | -0.46 | -1.50 | -0.93 | -3.69 | |
| EPS (Diluted) | -0.38 | -0.46 | -1.50 | -0.93 | -3.69 | |
| Free Cash Flow | -26.42 | -14.56 | -21.05 | -13.59 | -8.8 | |
| Free Cash Flow Per Share | -0.28 | -0.25 | -1.32 | -0.85 | -3.10 | |
| EBITDA | -39.69 | -29.91 | -25.06 | -14.87 | - | |
| D&A For EBITDA | 0.02 | 0.01 | 0.01 | 0.01 | - | |
| EBIT | -39.7 | -29.92 | -25.07 | -14.88 | -7.44 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.